Home
Latest
E-paper
Companies
Industry
Economy
WebinarsNew
Deep DiveNew
Blueprint
Finance
Markets
Budget
India News
Politics
External Affairs Defence Security
World News
Opinion
Technology
Immigration
Specials
Partner Content
Sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
Newsletters
Web Stories
BS at 50
Multimedia
Sudoku
Crossword
BS Apps
Management
Premium
Indulgence
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
Centre to cap trade margins on non-scheduled cancer drugs at 30%
Move could cut MRPs by up to 70%, save patients ₹2,500 crore annually; comes amid SC scrutiny of high mark-ups
Near-term growth issues and cost pressure could impact Aurobindo Pharma
While valuations are now attractive, product approvals and progress on the injectable guidance are among key long-term term triggers
NPPA vs Pharma makers: Industry body knocks Ananth Kumar's door over notice
NPPA issued show-cause notices to leading drug makers over 'suspected overcharging'
